Companion Diagnostics Market is expected to generate a revenue of USD 12,150.01 Million by 2030, Globally, at 13.11% CAGR: Verified Market Research®

The market report is a good combination of qualitative and quantitative data that highlights significant market changes, obstacles that business and the competition must overcome, as well as new possibilities and trends in the global Companion Diagnostics Market.

Boonton, New Jersey, UNITED STATES

Jersey City, New Jersey, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Verified Market Research® recently published a report, “Companion Diagnostics Market” By Technology Type (Frequency Immunohistochemistry, Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS)), By Indication (Oncology, Neurology), and By Geography.

As per the deep research carried out by Verified Market Research®, the global Companion Diagnostics Market size was valued at USD 4,009.99 Million in 2021 and is projected to reach USD 12,150.01 Million by 2030, growing at a CAGR of 13.11% from 2023 to 2030.

Download PDF Brochure:

Browse in-depth TOC onCompanion Diagnostics Market

202 - Pages

126 – Tables

37 – Figures

Global Companion Diagnostics Market Overview

Companion diagnostics are often used along with the primary therapeutic agents to evaluate their effects on the body. Companion diagnostics are developed along with the therapeutic agent with which they are used. It helps the healthcare professional to understand the efficacy of therapy in a selected group of patients. It helps in identifying which patients will respond positively to the therapeutic agents and which patients will respond adversely. Based on this data, the physician can identify whether to prescribe that drug to the patient in concern or not. Through such practices, the side effects, risks, and benefits of any drug can be managed effectively.

As the field of genetics and genetic engineering is growing rapidly, the idea of personalized medicine is getting more common. Based on a person's genetic traits, it is now possible to offer the right medicine to the right person at the right time. Many pharmaceutical and biopharmaceutical companies are developing targeted drug therapies as a part of a patient-centric drug development approach. Many third-party companion diagnostic services offer such services to companies with a higher financial burden. Because of this, the challenge of high initial costs has been addressed effectively. These factors collectively are expected to grow the market for companion diagnostics during the forecast period.

NGS-based companion diagnostic tests seek to extract molecular information from each patient’s tumor genome to guide cancer therapy decisions. When compared to other sequencing techniques, next-generation sequencing detects many biomarkers for multiple medication regimens in a quicker time frame. The use of NGS panels for biomarker evaluation in a single test has the potential to aid in the treatment of numerous malignancies.

Verified Market Research® narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements that interests the client. The “Global Companion Diagnostics Market” is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.

Key Players

The “Global Companion Diagnostics Market” study report will provide a valuable insight with an emphasis on the global market.  The major players in the market are Abbott Laboratories Molecular, Inc., Agilent (Dako Denmark A/S), ARUP Laboratories, Inc., BioMerieux, Danaher Corporation (Leica Microsystems), Foundation Medicine, Inc., Myriad Genetics, Inc., Roche (Ventana Medical Systems, Inc), Thermo Fisher Scientific (Life Technologies Corporation), QIAGEN N.V.

Based on the research, Verified Market Research® has segmented the global Companion Diagnostics Market into Technology Type, Indication, and Geography.

  • Companion Diagnostics Market, by Technology Type
    • Frequency Immunohistochemistry
    • Polymerase Chain Reaction (PCR)
    • Next Generation Sequencing (NGS)
    • In Situ Hybridization
    • Others
  • Companion Diagnostics Market, by Indication
    • Oncology
    • Neurology
    • Others
  • Companion Diagnostics Market, by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

U.S. Pharmacogenomics (PGx) Testing Market By Test Type(single gene tests, array-based tests, whole genome sequencing), By Sample Type(blood, saliva), By Application(oncology, neurology, cardiology, genomics), By End–User(hospitals, clinics, diagnostic laboratories), By Distribution Channel(hospital pharmacies, retail pharmacies), By Geography, And Forecast

Radiopharmaceuticals Market By Procedural Volume (Diagnostic Procedures, Therapeutic Procedures), By Application (Oncology, Cardiology, Neurology), By Geography, And Forecast

Flow Cytometry Market By Technology (Cell-Based Flow Cytometry, and Bead-Based Flow Cytometry), By Product And Service (Instruments, Reagents and Consumables), By End-User (Hospitals and Diagnostic Laboratories, Biotechnology and Biopharmaceutical Companies), By Application (Industrial Applications, Clinical Applications, Research Applications), By Geography, And Forecast

Rapid Diagnostic Kits Market By Product (Lateral Flow Test, Agglutination Assays, Flow Through, Solid Phase), By Application (Hospitals and Clinical Testing, Home Testing, Veterinary Testing, Other), By Geography, And Forecast

Top 10 Point-Of-Care Molecular Diagnostics Companies supplying improved testing methods

Visualize Companion Diagnostics Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research® is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research® provides advanced analytical research solutions while offering information-enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME’s offer a high level of expertise in data collection and governance and use industrial techniques to collect and analyze data on more than 15,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductors & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & Construction, Agriculture industry and Medical Devices from over 100 countries.


Contact Data